Lantern Pharma Inc.LTRNNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank86
3Y CAGR+10.8%
5Y CAGR+27.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+10.8%/yr
vs +70.0%/yr prior
5Y CAGR
+27.1%/yr
Recent deceleration
Acceleration
-59.3pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
3.3x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $19.62M | -11.7% |
| 2024 | $22.22M | +25.5% |
| 2023 | $17.70M | +22.7% |
| 2022 | $14.43M | +14.6% |
| 2021 | $12.59M | +113.1% |
| 2020 | $5.91M | +143.3% |
| 2019 | $2.43M | +40.6% |
| 2018 | $1.73M | - |